Viewing Company
Company Name:
Lomond Therapeutics Holdings, Inc.
CIK:
1900520
Phone:
None
Fiscal Year End:
None
Entity Type:
SIC:
-
Category Type:
Entity Name:
None
First Filing Date:
2022-05-16
Last Filing Date:
2025-04-15
SEC Filings
| Start | End | Frame | Filed | ACCN | Value | View |
|---|---|---|---|---|---|---|
| 2022-01-01 | 2022-03-31 | CY2022Q1 | 2022-05-16 | 0001213900-22-027252 | $ 5,000,000 | View |
| 2022-04-01 | 2022-06-30 | CY2022Q2 | 2022-08-15 | 0001213900-22-048222 | $ 5,000,000 | View |
| 2022-07-01 | 2022-09-30 | CY2022Q3I | 2022-11-14 | 0001213900-22-071357 | $ 0 | View |
| 2021-09-24 | 2021-12-31 | CY2021Q4 | 2023-03-31 | 0001213900-23-025543 | $ 500 | View |
| 2023-01-01 | 2023-03-31 | CY2023Q1 | 2023-05-15 | 0001213900-23-039651 | $ 2,665 | View |
| 2023-01-01 | 2023-06-30 | CY2023Q2I | 2023-08-10 | 0001213900-23-065654 | $ 83,100 | View |
| 2023-01-01 | 2023-09-30 | CY2023Q3I | 2023-11-13 | 0001213900-23-086213 | $ 93,100 | View |
| 2023-01-01 | 2023-03-31 | CY2023Q1 | 2024-05-14 | 0001213900-24-042959 | $ 120 | View |
| 2023-01-01 | 2023-06-30 | CY2024Q2I | 2024-08-13 | 0001213900-24-068368 | $ 120 | View |
| 2023-01-01 | 2023-09-30 | CY2024Q3I | 2024-10-28 | 0001213900-24-091191 | $ 120 | View |
| 2023-01-01 | 2023-12-31 | CY2023 | 2024-04-01 | 0001213900-24-028660 | $ 120 | View |
| 2024-01-01 | 2024-12-31 | CY2024 | 2025-04-15 | 0001213900-25-032200 | $ 4,400,000 | View |
SEC Facts By Type
| Type | Name | Description | View |
|---|---|---|---|
| us-gaap | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. | View |
| us-gaap | Stockholders' Equity Attributable to Parent | Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. | View |
| us-gaap | Market Risk Benefit, Change in Fair Value, Gain (Loss) | Amount of gain (loss) from (increase) decrease in fair value of contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk. Excludes change attributable to instrument-specific credit risk. | View |
| us-gaap | Money Market Funds, at Carrying Value | Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months. | View |
| us-gaap | Repayments of Related Party Debt | The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates. | View |
| us-gaap | Accounts Payable and Other Accrued Liabilities, Current | Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer. | View |
| us-gaap | Additional Paid in Capital | Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. | View |
| us-gaap | Adjustments to Additional Paid in Capital, Other | Amount of other increase (decrease) in additional paid in capital (APIC). | View |
| us-gaap | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. | View |
| us-gaap | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. | View |
| us-gaap | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. | View |
| us-gaap | Common Stock, Capital Shares Reserved for Future Issuance | Aggregate number of common shares reserved for future issuance. | View |
| us-gaap | Deferred Tax Assets, in Process Research and Development | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards. | View |
| us-gaap | Deferred Tax Assets, Other | Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other. | View |
| us-gaap | Deferred Tax Assets, Tax Credit Carryforwards, Research | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. | View |
| us-gaap | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. | View |
| us-gaap | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other | Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other. | View |
| us-gaap | Deferred Tax Assets, Valuation Allowance | Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. | View |
| us-gaap | Fair Value Adjustment of Warrants | Amount of expense (income) related to adjustment to fair value of warrant liability. | View |
| us-gaap | Fair Value, Option, Changes in Fair Value, Gain (Loss) | For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings. | View |
| us-gaap | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. | View |
| us-gaap | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | Amount of increase (decrease) in accrued expenses, and obligations classified as other. | View |
| us-gaap | Increase (Decrease) in Prepaid Expense | The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. | View |
| us-gaap | Interest Expense, Debt | Amount of the cost of borrowed funds accounted for as interest expense for debt. | View |
| us-gaap | Interest Income and Fees, Bankers Acceptances, Certificates of Deposit and Commercial Paper | Interest and fee income derived from banker's acceptances, certificates of deposit and commercial paper. | View |
| us-gaap | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. | View |
| us-gaap | Noninterest Expense Directors Fees | Noninterest expense related to directors' fees which are fees paid by an Entity to its directors. Directors' fees may be paid in addition to salary and other benefits. | View |
| us-gaap | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). | View |
| us-gaap | Number of Operating Segments | Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. | View |
| us-gaap | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. | View |
| us-gaap | Other Accrued Liabilities, Current | Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. | View |
| us-gaap | Other Expenses | Amount of expense classified as other. | View |
| us-gaap | Other Noncash Expense | Amount of expense or loss included in net income that result in no cash flow, classified as other. | View |
| us-gaap | Other Prepaid Expense, Current | Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. | View |
| us-gaap | Payments of Capital Distribution | Cash outflow to owners or shareholders, excluding ordinary dividends. Includes special dividends. | View |
| us-gaap | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. | View |
| us-gaap | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. | View |
| us-gaap | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. | View |
| us-gaap | Prepaid Insurance | Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer. | View |
| us-gaap | Proceeds from Contributed Capital | The cash inflow associated with the amount received by a corporation from a shareholder during the period. | View |
| us-gaap | Research and Development Expense | The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. | View |
| us-gaap | Share-based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | The risk-free interest rate assumption that is used in valuing an option on its own shares. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Gross number of share options (or share units) granted during the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Number of options outstanding, including both vested and non-vested options. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased | Per share weighted-average price paid for shares purchased on open market for issuance under share-based payment arrangement. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award | Number of shares purchased for issuance under share-based payment arrangement. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. | View |
| us-gaap | 4234759 | None | View |
| us-gaap | Stock Issued During Period, Shares, Issued for Services | Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. | View |
| us-gaap | Stock Issued During Period, Shares, Stock Splits | Number of shares issued during the period as a result of a stock split. | View |
| us-gaap | Stock Issued During Period, Value, Conversion of Convertible Securities | The gross value of stock issued during the period upon the conversion of convertible securities. | View |
| us-gaap | Stock Issued During Period, Value, Conversion of Units | Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit). | View |
| us-gaap | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. | View |
| dei | Entity Common Stock, Shares Outstanding | Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. | View |
| dei | Entity Public Float | The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. | View |
| us-gaap | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. | View |
| us-gaap | Additional Collateral, Aggregate Fair Value | The aggregate fair value of additional assets that would be required to be posted as collateral for derivative instruments with credit-risk-related contingent features if the credit-risk-related contingent features were triggered at the end of the reporting period. | View |
| us-gaap | Assets | Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Assets, Current | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | View |
| us-gaap | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | View |
| us-gaap | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | View |
| us-gaap | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | View |
| us-gaap | Customer Advances, Current | The current portion of prepayments received from customers for goods or services to be provided in the future. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates. | View |
| us-gaap | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | Percentage of domestic federal statutory tax rate applicable to pretax income (loss). | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. | View |
| us-gaap | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. | View |
| us-gaap | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. | View |
| us-gaap | Liabilities | Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. | View |
| us-gaap | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. | View |
| us-gaap | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | View |
| us-gaap | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | View |
| us-gaap | Notes Payable | Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. | View |
| us-gaap | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. | View |
| us-gaap | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. | View |
| us-gaap | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | View |
| us-gaap | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | View |
| us-gaap | Retained Earnings (Accumulated Deficit) | The cumulative amount of the reporting entity's undistributed earnings or deficit. | View |
| us-gaap | Stockholders' Equity, Other | This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy. | View |
| us-gaap | Stock Issued During Period, Value, Issued for Services | Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. | View |
| us-gaap | Weighted Average Number Diluted Shares Outstanding Adjustment | The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation. | View |
| us-gaap | Deferred Revenue, Revenue Recognized | Amount of revenue recognized that was previously reported as deferred or unearned revenue. | View |
| us-gaap | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | View |
| us-gaap | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. | View |
| us-gaap | Proceeds from Notes Payable | The cash inflow from a borrowing supported by a written promise to pay an obligation. | View |
| us-gaap | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | View |
| us-gaap | Derivative, Variable Interest Rate | Variable interest rate in effect as of the balance sheet date related to the interest rate derivative. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Percent | Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. | View |
| us-gaap | Interest Costs Incurred | Total interest costs incurred during the period and either capitalized or charged against earnings. | View |
| us-gaap | Issuance of Stock and Warrants for Services or Claims | Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. | View |
| us-gaap | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. | View |
| us-gaap | Proceeds from Issuance or Sale of Equity | The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. | View |
| us-gaap | Proceeds from Related Party Debt | The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. | View |
| us-gaap | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. | View |
| us-gaap | Accumulated Capitalized Interest Costs | Amount of accumulated interest costs capitalized as part of property, plant and equipment cost basis. | View |
| us-gaap | Increase (Decrease) in Accounts Payable, Related Parties | The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence. | View |
| us-gaap | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Deferred Tax Assets, Gross | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. | View |
| us-gaap | Operating Loss Carryforwards | Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. | View |
Chart of Accounts => Accounts
| Name | View |
|---|---|
| Accounts Payable and Other Accrued Liabilities, Current | View |
| Additional Paid in Capital | View |
| Adjustments to Additional Paid in Capital, Other | View |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | View |
| Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | View |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | View |
| Common Stock, Capital Shares Reserved for Future Issuance | View |
| Deferred Tax Assets, in Process Research and Development | View |
| Deferred Tax Assets, Operating Loss Carryforwards | View |
| Deferred Tax Assets, Operating Loss Carryforwards, Foreign | View |
| Deferred Tax Assets, Operating Loss Carryforwards, State and Local | View |
| Deferred Tax Assets, Other | View |
| Deferred Tax Assets, Tax Credit Carryforwards, Research | View |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | View |
| Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other | View |
| Deferred Tax Assets, Valuation Allowance | View |
| Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | View |
| Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent | View |
| Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | View |
| Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | View |
| Fair Value Adjustment of Warrants | View |
| Fair Value, Option, Changes in Fair Value, Gain (Loss) | View |
| Increase (Decrease) in Accounts Payable | View |
| Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | View |
| Increase (Decrease) in Prepaid Expense | View |
| Interest Expense, Debt | View |
| Interest Income and Fees, Bankers Acceptances, Certificates of Deposit and Commercial Paper | View |
| Investment Income, Interest | View |
| Noninterest Expense Directors Fees | View |
| Nonoperating Income (Expense) | View |
| Number of Operating Segments | View |
| Operating Expenses | View |
| Other Accrued Liabilities, Current | View |
| Other Expenses | View |
| Other Noncash Expense | View |
| Other Prepaid Expense, Current | View |
| Payments of Capital Distribution | View |
| Payments of Stock Issuance Costs | View |
| Prepaid Expense and Other Assets, Current | View |
| Prepaid Expense, Current | View |
| Prepaid Insurance | View |
| Proceeds from Contributed Capital | View |
| Research and Development Expense | View |
| Share-based Payment Arrangement, Noncash Expense | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | View |
| 4197977 | View |
| Stock Issued During Period, Shares, Issued for Services | View |
| Stock Issued During Period, Shares, Stock Splits | View |
| Stock Issued During Period, Value, Conversion of Convertible Securities | View |
| Stock Issued During Period, Value, Conversion of Units | View |
| Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | View |
| Accounts Payable and Accrued Liabilities, Current | View |
| Additional Collateral, Aggregate Fair Value | View |
| Assets | View |
| Assets, Current | View |
| Cash and Cash Equivalents, at Carrying Value | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | View |
| Common Stock, Par or Stated Value Per Share | View |
| Common Stock, Shares Authorized | View |
| Common Stock, Shares, Issued | View |
| Common Stock, Shares, Outstanding | View |
| Common Stock, Value, Issued | View |
| Customer Advances, Current | View |
| Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration | View |
| Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration | View |
| Earnings Per Share, Basic | View |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | View |
| Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | View |
| General and Administrative Expense | View |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | View |
| Liabilities | View |
| Liabilities and Equity | View |
| Net Cash Provided by (Used in) Operating Activities | View |
| Net Income (Loss) Attributable to Parent | View |
| Notes Payable | View |
| Notes Payable, Current | View |
| Operating Income (Loss) | View |
| Preferred Stock, Par or Stated Value Per Share | View |
| Preferred Stock, Shares Authorized | View |
| Retained Earnings (Accumulated Deficit) | View |
| Stockholders' Equity Attributable to Parent | View |
| Stockholders' Equity, Other | View |
| Stock Issued During Period, Value, Issued for Services | View |
| Weighted Average Number Diluted Shares Outstanding Adjustment | View |
| Deferred Revenue, Revenue Recognized | View |
| Earnings Per Share, Diluted | View |
| Market Risk Benefit, Change in Fair Value, Gain (Loss) | View |
| Money Market Funds, at Carrying Value | View |
| Net Cash Provided by (Used in) Financing Activities | View |
| Proceeds from Notes Payable | View |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | View |
| Weighted Average Number of Shares Outstanding, Diluted | View |
| Weighted Average Number of Shares Outstanding, Basic | View |
| Derivative, Variable Interest Rate | View |
| Effective Income Tax Rate Reconciliation, Percent | View |
| Interest Costs Incurred | View |
| Issuance of Stock and Warrants for Services or Claims | View |
| Proceeds from Issuance of Common Stock | View |
| Proceeds from Issuance or Sale of Equity | View |
| Proceeds from Related Party Debt | View |
| Stock Issued During Period, Value, New Issues | View |
| Accumulated Capitalized Interest Costs | View |
| Increase (Decrease) in Accounts Payable, Related Parties | View |
| Liabilities, Current | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | View |
| Deferred Tax Assets, Gross | View |
| Operating Loss Carryforwards | View |
| Repayments of Related Party Debt | View |